EGFR and lung adenocarcinoma: For example, the epidermal growth factor receptor (EGFR) mutation rate of lung adenocarcinoma patients in China is 61%, while that in the United States is only 11%.2 Cancer is a heterogeneous disease characterized by cell death disorder.